Liver, mitochondria and insulin resistance
MOTS-c 20mg, Mitochondrial dysfunction in the liver can promote ectopic lipid accumulation , reduced fat oxidation, and the onset of insulin resistance . In unfavorable dietary scenarios (e.g., high-fat diets or excessive fructose), mitochondria lose efficiency, with cascading effects on obesity , hepatic steatosis , and altered glucose metabolism. MOTS-c, by modulating cellular energy programs and the redox system, is being studied as a lever to restore a more favorable metabolic balance and counteract the key features of hepatic metabolic dysfunction.
In summary
MOTS-c is a bioenergetic modulator that acts on multiple fronts: muscle (glucose uptake and mitochondrial efficiency), adipose tissue (lipid oxidation, thermogenesis, inflammation), liver (redox balance and lipid management), bone (collagen and osteogenic differentiation), and endothelium (vascular reactivity). Through pathways such as AMPK and TGF-β/SMAD , it helps restore energy homeostasis and support cellular resilience . This profile makes it a molecule of primary interest in the biology of aging and metabolic disorders, always and exclusively within the scope of laboratory research .





Reviews
There are no reviews yet.